Printer Friendly

Investigating the chaperone properties of a novel heat shock protein, Hsp70.c, from Trypanosoma brucei.

The neglected tropical disease, African Trypanosomiasis, is fatal and has a crippling impact on economic development. Heat shock protein 70 (Hsp70) is an important molecular chaperone that is expressed in response to stress and Hsp40 acts as its co-chaperone. These proteins play a wide range of roles in the cell and they are required to assist the parasite as it moves from a cold blooded insect vector to a warm blooded mammalian host. A novel cytosolic Hsp70, from Trypanosoma brucei, TbHsp70.c, contains an acidic substrate binding domain and lacks the C-terminal EEVD motif. The ability of a cytosolic Hsp40 from Trypanosoma brucei J protein 2, Tbj2, to function as a co-chaperone of TbHsp70.c was investigated. The main objective was to functionally characterize TbHsp70.c to further expand our knowledge of parasite biology. TbHsp70.c and Tbj2 were heterologously expressed and purified and both proteins displayed the ability to suppress aggregation of thermolabile MDH and chemically denatured rhodanese. ATPase assays revealed a 2.8-fold stimulation of the ATPase activity of TbHsp70.c by Tbj2. TbHsp70.c and Tbj2 both demonstrated chaperone activity and Tbj2 functions as a co-chaperone of TbHsp70.c. In vivo heat stress experiments indicated upregulation of the expression levels of TbHsp70.c.

1. Introduction

Molecular chaperones are essential for the maintenance of cellular homeostasis by facilitating various functions including degradation of proteins [1], translocation [2], folding of co-translational products [3], and protein complex assembly [4]. Many molecular chaperones are also known as heat shock proteins (Hsp) and their expression is upregulated in response to stress. The large and varied heat shock protein family has usually been classified into major classes defined by molecular weight.

The 70 kDa family of proteins is the most abundant and thoroughly studied family of heat shock proteins [5]. Hsp70 functions both as a holdase (binding and holding onto unfolded polypeptides by withdrawing aggregation-prone species) as well as a refoldase (assisting non-native proteins to fold to the native state) [6]. The highly conserved Hsp70 structure is typically composed of an N-terminal ATPase domain (44 kDa), a C-terminal domain containing a [beta]-sandwich subdomain, which is the substrate binding domain (15-18 kDa,) followed by an [alpha]-helical subdomain (10 kDa) [7, 8].

Hsp70 protein activity occurs through the interaction of hydrophobic peptide segments of other proteins with its substrate binding domain (SBD) in an ATP-dependent manner. The Hsp70 ATPase cycle switches between the low affinity ATP-bound state and rapid substrate-exchange rates and the high affinity ADP-bound state with low substrate-exchange rates [9]. Hsp40 is a co-chaperone and is required to stimulate the ATPase activity of Hsp70 and results in Hsp70-ADP with a high affinity for substrate. In order for the nucleotide binding cleft to be opened, the release of ADP is facilitated by a nucleotide-exchange factor, such as Bag-1 protein. The ATPase cycle is completed when ATP binds the ATPase domain of Hsp70 resulting in a conformational change in the substrate binding domain and bound substrates are released [10]. The EEVD motif present at the end of the C-terminus of Hsp70 members is involved in binding to the tetratricopeptide repeat (TPR) domains of Hsp70/Hsp90 organizing protein (Hop) and carboxy terminus of Hsp70 interacting protein (CHIP) [11]. The EEVD motif has been suggested to recruit Hsp40 as it has been shown to bind and regulate the function of Hsp40 [12, 13].

All Hsp40s contain a J-domain that is required for facilitating the cellular activity of Hsp70 proteins through its interaction with their partner Hsp70s. The J-domain has a conserved Histidine-Proline-Aspartic acid (HPD) tripeptide; variations within the HPD motif are known to abolish the stimulation of Hsp70 ATPase activity by Hsp40 [14, 15]. Hsp40s have been divided into three classes based on which functional domains they contain. Type I Hsp40s are highly conserved and contain a glycine-phenylalanine (G/F) and cysteine rich region that contains four motifs of CXXCXGXG, a glycine/methionine rich region, a carboxy-terminal peptide binding domain and a dimerization domain [16, 17]. Type I Hsp40s also have a peptide-binding region at the C-terminus which aids in the binding to non-native polypeptides, in turn allowing Hsp40 proteins to transport substrates to Hsp70 proteins for folding [18, 19]. Type II Hsp40s contain the J-domain and the G/F rich region, along with the peptide-binding region at the C-terminus [20-22]. Both Types I and II serve to bind substrates and target them to Hsp70 [22]. The highly specialized Type III Hsp40s possess only the conserved J-domain which can occur anywhere on its sequence [23] and primarily functions to recruit Hsp70 to a particular location [22].

The African trypanosome, Trypanosoma brucei, is a blood-borne unicellular parasitic protozoan and the etiological agent of both human and animal African Trypanosomiasis [24]. African Trypanosomiasis is described as one of the neglected tropical diseases crippling economic development and causing death in Africa's poorest and most marginalized communities. Due to a lack of new treatments against human African Trypanosomiasis and emergence of resistance to older drugs, human treatments currently available are connected with high levels of toxicity and resistance [25]. Heat shock proteins have been emerging as prospective drug targets (Hsp70s as drug targets reviewed in [26]). Drugs causing cellular stress resulting in the induction of heat shock proteins have been discovered to ultimately improve cytoprotection [27, 28]. Anti-heat shock protein drugs used in combination with current drugs could therefore synergistically improve the effectiveness of available drugs.

Parasitic heat shock proteins have been revealed as drug targets, including malarial drug target P. falciparum Hsp90 and trypanosomal T. evansi Hsp90 [29, 30]. Amongst the known Hsp90 proteins, PfHsp90 was shown to have the highest ATPase activity, and its inhibition by geldanamycin (GA) was stronger than seen for human Hsp90 [30]. Semi-synthetic inhibitor 17-(allylamino)-17-demethoxygeldanamycin (17-AAG) has been shown to curb growth of the P. falciparum parasite and to inhibit the growth of the T. evansi parasite by specifically binding and inhibiting Hsp90 [30]. 17-AAG could likely be effective against infection caused by T. brucei due to the sequence similarity between TbHsp90 and TeHsp90 [30]. Sera from patients infected with trypanosomes were screened to identify diagnostic antigens, and although TbHsp70 was identified as a candidate, by itself, it demonstrated inadequate specificity and sensitivity in diagnosis of trypanosomiasis [23]. It may however be useful as a diagnostic antigen if used in conjunction with other immunogenic proteins [23].

Of the Leishmanial and trypanosomal Hsp70s and Hsp40s, a number of important and well-known studies have been performed on T. cruzi. Cytoplasmic TcHsp70B demonstrated high ATPase activity in comparison to human Hsp70 [31] and was shown to be heat inducible [32]. In addition to stimulating the immune response [33], TcHsp70B is one of the immunodominant antigens in T. cruzi infected individuals [31, 33]. A Type I Hsp40, Tcj2, was able to stimulate the already high basal ATPase activity of TcHsp70B by 1.5 fold, whilst the Type III Hsp40 Tcj1 showed no significant stimulation [34]. Furthermore, Tcj2 was shown to complement the well-characterized Saccharomyces cerevisiae Type I Hsp40, Ydj1, and was subsequently suggested to be involved in cytoprotection [34]. TcHsp70B, displaying typical chaperone properties, is homologous to T. brucei Hsp70, and Tcj1 and Tcj2 are homologous to Tbj1 and Tbj2, respectively [35].

Genome annotation revealed T. brucei to possess a complement of 65 Hsp40 proteins and 12 Hsp70 proteins [35]. In silico analysis of TbHsp70.c indicated the presence of atypical acidic residues in the substrate binding domain as well as in the substrate binding cavity of TbHsp70.c [36] and these may play a role in substrate discrimination. However, the residues required for association with Hsp40 proteins within both the ATPase and substrate binding cavity, as well as the Hsp70 phosphorylation site, are well conserved. In addition the C-terminal EEVD motif is absent from TbHsp70.c and it contains the sequence RIEAINANTE at the end of the protein [36]. TbHsp70.c was predicted to be cytoplasmic [36]. To date, TbHsp70.c has not been biochemically characterized and co-chaperones have not been identified. Of the 65 Hsp40s, only one of the Type III T. brucei Hsp40 proteins, Tbj1, has been expressed, purified, and biochemically characterized to date [37]. No in vitro characterization of the Type I T. brucei Hsp40 protein, Tbj2, has been completed; in vivo analysis revealed that Tbj2 is essential to the survival of the cell [38, 39]. Tbj2 was demonstrated to be upregulated upon inducing heat shock and to localize in the cytoplasm [39]. According to TriTrypDB [40], TbHsp70.c is localized in the cytoplasm and Tbj2 was selected as a probable partner of TbHsp70.c. This research aims to functionally characterize TbHsp70.c and Tbj2 as its potential co-chaperone. We successfully expressed and purified TbHsp70.c and revealed for the first time that TbHsp70.c and Tbj2 can prevent thermal aggregation of malate dehydrogenase (MDH) and rhodanese and that Tbj2 stimulates the ATPase activity of TbHsp70.c. We report here that TbHsp70.c and Tbj2 have properties of molecular chaperones. A greater understanding of the Hsp70-Hsp40 partnerships is important as molecular chaperones have been implicated in parasite survival and growth.

2. Materials and Methods

2.1. Materials. Reagents used were purchased from Sigma Chemicals Co. (St. Louis, Mo USA), Merck Chemicals (Darmstadt, Germany), BioRad (USA), or Roche Molecular Biochemicals (Indianapolis, IN, USA). Nickel NTA resin was purchased from Pharmacia Biotech (Uppsala, Sweden). Anti-His antibody was purchased from GE Healthcare. Anti-TbHsp70.c was produced by and purchased from GenScript (USA). Plasmid TcHsp70B was a gift from Dr. D. Engman (Northwestern University Medical School, Chicago, USA). The T. brucei TREU927 strain was a kind donation from Professor George Cross (Rockefeller University, New York, USA). E. coli strain BB1994 (MC4100 dnaK52 sidB1::Tc pDMI,1::CmR KanR) was kindly provided by Dr. M. Mayer (Heidelberg University, Heidelberg, Germany).

2.2. Conservation Level of Cytoplasmic Hsp70 and Hsp40 Proteins from the Tritryps. Prior to phylogenetic tree analysis, trypanosomatid amino acid sequences were obtained from the GeneDB database [41] and other Hsp70 protein sequences were retrieved from the National Centre for Biotechnology Information (NCBI) [42], both sets of sequences in FASTA format. The accession numbers of all retrieved sequences are given in Figure 1. The multiple sequence analysis was performed using Muscle [44]. The phylogenetic tree was generated using Molecular Evolutionary Genetics Analysis (MEGA5) version 5.2.2 maximum likelihood analysis [43].

2.3. Construction of Expression Vectors pQE80-TbHsp70.c and pET28a-Tbj2. The coding regions of full length TbHsp70.c and Tbj2 were PCR amplified from T. b. brucei TREU927 genomic DNA. Forward primer (5'-GGT ACC ATG ACC TAC GAA GGA-3') with a KpnI restriction site (underlined) and reverse primer (5'-GTC GAC TTA CTC TGT GTT TGC-3') with a SalI restriction site (underlined) were used for TbHsp70.c. The forward (5'-GAATTCGGATCCCATATGGTGAAAGAAACAAAATAC-3') (EcoRI, BamHI, NdeI) and reverse (5'-AAGCTTCTCGAGGTCGACCTATTGCTGCGTACACG-3') (HindIII, XhoI, SalI) primers were used for PCR amplification of Tbj2. The N-terminal His-tagged pQE80-TbHsp70.c and pET28a-Tbj2 constructs were verified by restriction digestion analysis and DNA sequencing (data not shown).

2.4. TbHsp70.c, TcHsp70B, and Tbj2 Protein Expression and Purification. An overnight culture was prepared by inoculating E. coli BB1994 [pQE80TbHsp70.c] in 25 mL 2 x YT broth supplemented with 100 [micro]g/mL ampicillin and 50 [micro]g/mL kanamycin at 30[degrees]C with shaking. The overnight culture was transferred to 225 mL 2 x YT broth and grown with shaking to midlog phase ([A.sub.600] 0.6) before inducing TbHsp70.c protein expression by the addition of isopropylthiogalactoside (IPTG) to a final concentration of 1 mM. Cells were harvested (5000 g; 15 min) 3 hours after induction and resuspended in lysis buffer (100 mM Tris-HCl, pH 8, 300 mM NaCl, 10 mM imidazole). Cells were stored at -80[degrees]C overnight and thawed with the addition of 1 mg/L lysozyme and 1 mM PMSF culminating in lysis. Cellular debris was removed by centrifugation (12000 g; 40 min; 4[degrees]C) and the supernatant was incubated with nickel-charged sepharose beads in lysis buffer overnight at 4[degrees]C. The bead-suspension was centrifuged (5000 g; 1min; 4[degrees]C) and three washes were performed with wash buffer (100 mM Tris-HCl, pH 8, 300 mM NaCl, 20 mM imidazole). Bound protein was eluted with 500 mM imidazole. Purified protein was subsequently dialysed overnight [100 mM Tris-HCl, pH8, 100 mM NaCl, 5% (v/v) glycerol, 50 mM KCl, 2 mM Mg[Cl.sub.2], 0.5 mM dithiothreitol]. Purification of Tbj2 and TcHsp70B was adapted from the protocol carried out for TbHsp70.c. Both E. coli BL21(DE3) [pET28a-Tbj2] and BL21(DE3) [pET14b-TcHsp70B] cells were grown at 37[degrees]C, maintaining a selective pressure using kanamycin (50 [degrees]g/mL) and were harvested 5 hours after induction. To remove the presence of co-purified DnaK, Tbj2 and TcHsp70B bound to the Ni-NTA column were washed 5 times with the addition of 20% glycerol and 10 mM ATP to the wash buffer. All of other steps of the purification were performed in the same manner as for TbHsp70.c. Purified protein was quantified using Bradford's assay. Sodium-dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) analysis was used to evaluate the purity of the protein. Anti-TbHsp70.c was produced in rabbit using the C-terminal antigen, CQRGRGVTEGSGRPP at residues 648-662, from the TbHsp70.c protein sequence. Western analysis was used to verify the integrity and identity of TbHsp70.c using affinity-purified anti-TbHsp70.c peptide antibody. Western analysis was performed using anti-His antibody to target Tbj2 and TcHsp70B and anti-DnaK antibody to detect DnaK. Antibodies were detected using the ECL Advance Blotting Detection Kit and viewed using the Chemidoc EQ (BioRad, USA).

2.5. Aggregation Suppression Assays

2.5.1. Suppression of Rhodanese Aggregation. The ability of TbHsp70.c and Tbj2 to suppress aggregation of bovine rhodanese (Sigma-Aldrich) was assessed spectrophotometrically. The assay was modified from [45]. Rhodanese was denatured overnight at 30[degrees]C; rhodanese denatured in denaturing buffer (6 M guanidine hydrochloride, 50 mM HEPES, pH 7.0, 100 mM NaCl) was added to assay buffer (50 mM HEPES, pH 7.0, 100 mM NaCl) to a final concentration of 1.5 [micro]M and was monitored at 300 nm over a period of 40 min at room temperature using a KC Junior microplate reader (Bio-Tek Instruments, USA). Molecular chaperone proteins of interest were added at various concentrations to measure their ability to suppress rhodanese aggregation. TcHsp70B was used as a positive control. TbHsp70.c, TcHsp70B, and Tbj2 are not aggregation prone as no significant increase in turbidity was observed when these proteins were assayed in the absence of rhodanese; protein samples that had been inactivated by boiling for 20 minutes also displayed no chaperone activity (data not shown). Absorbance was plotted as percent rhodanese aggregation over 40 min subsequent to normalizing against assays with rhodanese alone.

2.5.2. Suppression of Malate Dehydrogenase (MDH) Aggregation. The abilities of TbHsp70.c and Tbj2 to prevent thermal aggregation of MDH were analysed by spectrophotometry. The assay was carried out as described by Botha and colleagues [46]. The assay was initiated by adding 0.72 [micro]M MDH and the molecular chaperone proteins to assay buffer (50 mM Tris-HCl, 100 mM NaCl; pH7.4) heated to 48[degrees]C. Aggregation of the protein substrate was monitored by measuring the scatter of light at 360 nm over 30 min at 48[degrees]C in a Helios Alpha DB spectrophotometer with a Peltier-controlled cell. Protein aggregation was assayed using varying concentrations of chaperone protein. The same controls as for the suppression of rhodanese assay were used.

2.6. ATPase Activity Assays. Hydrolysis of ATP by TbHsp70.c was assessed using a modified version of the ascorbic acid/ammonium molybdate colorimetric assay to measure the release of inorganic phosphate during the reaction [47]. The assay was performed as described in [37] with a few modifications. TbHsp70.c and control protein TcHsp70B (0.4 [micro]M) were equilibrated to 37[degrees]C in ATPase buffer (25 mM HEPES, pH 7.4, 2 mM Mg[Cl.sub.2], 50 mM KCl, 0.5 mM DTT). Stimulation of the basal ATPase activity of both TbHsp70.c and TcHsp70B by co-chaperone Tbj2 was assessed at equal concentrations (0.4 [micro]M) and in a 2-fold molar excess to TbHsp70.c (1 [micro]M) and TcHsp70B (1 [micro]M). Samples were taken in triplicate at regular time intervals (0, 30, 60, 120, 180, and 240 minutes). All assays were corrected for the spontaneous breakdown of ATP observed in a control experiment in the absence of protein. Any background ATP hydrolysis observed for Tbj2 was corrected by subtracting this activity from the reactions containing this protein.

2.7. Statistical Analysis. Statistical analysis was performed on data generated from both the aggregation suppression and ATPase activity assays. The relationship between two variables was analysed using one-way analysis of variance (ANOVA). Comparisons producing a P value < 0.05 were considered significant.

2.8. Detection of TbHsp70.c in T. brucei Lysates under Conditions of Heat Stress. Wild type Lister 927 variant 221 T. brucei brucei bloodstream form lysates ([10.sup.6] cells/mL) were used for the heat stress inducibility experiment. Bloodstream form T. brucei Lister 927 variant 221 strain trypanosome parasites were cultured in filter sterilized complete Iscoves Modified Dulbeccos Media (IMDM) based HM1-9 medium [IMDM base powder, 3.6 mM sodium bicarbonate, 1 mM hypoxanthine, 1 mM sodium pyruvate, 0.16 mM thymidine, 0.05 mM bathocuprone sulphate acid, 10% (v/v) heat inactivated Foetal Bovine Serum, 1.5 mM L-cysteine, 0.2 mM [beta]-mercaptoethanol, pH 7.5] in a humidified chamber at 37[degrees]C with an atmosphere of 5% C[O.sub.2]. Separate 25 mL culture of cells were exposed to heat shock at 42[degrees]C for a period of 60 min in plugged flasks, allowing no entry of C[O.sub.2]. A control experiment was performed under the same conditions-maintaining the temperature at 37[degrees]C. Cell lysates were harvested by centrifugation at 800 g for 10 min, washed twice in PBS buffer (10 mM [Na.sub.2]HP[O.sub.4], 2 mM K[H.sub.2]P[O.sub.4], 137 mM NaCl, 2.7 mM KCl), and repelleted prior to resuspension in SDS-PAGE loading buffer to a final cell count of 5 x [10.sup.5] cells/[micro]L. The lysates (5 x [10.sup.6] cells per lane) were resolved on a 10% SDS-PAGE gel. Differences in TbHsp70.c protein expression were detected using polyclonal rabbit anti-TbHsp70.c peptide antibody (1 : 5000) and goat anti-rabbit IgG HRP-conjugated secondary antibody (1 : 5000) in subsequent western analysis.

3. Results

Bioinformatic analysis revealed T. brucei Hsp70.c to be a eukaryotic isoform that may represent a novel family of Hsp70 proteins as it did not cluster phylogenetically with any of the other primary Hsp70 proteins [24]. Phylogenetic tree analysis was used to establish orthology between the novel Hsp70.c proteins within the TriTryps and to compare their phylogenetic relationships with cytoplasmic Hsp70s from the TriTryps and the Hsp70s from the T. brucei complement along with well-characterized eukaryotic and prokaryotic canonical Hsp70 proteins (Figure 1). TbHsp70.c may prove to be an anti-parasitic drug target as phylogenetic analysis suggests that TbHsp70.c clusters only with Hsp70 proteins from the Tritryps. Not surprisingly, the Hsp70.c proteins clustered together phylogenetically, TbHsp70.c formed a monophyletic clade with TbgHsp70.c and a close link with TcoHsp70.c, suggesting possible paralogy. The Hsp70.c cluster formed a closer phylogenetic relationship with the cytoplasmic Hsp70s, including inducible human Hsp70B (HsHSPA6), constitutively expressed human Hsc70 (HsHSPA8), bovine Hsc70 and plant Hsp70 than with mitochondrial Hsp70s, the NEF-acting Hsp110s, or the DnaKs (prokaryotic Hsp70 homologue) (Figure 1).

Recombinant TbHsp70.c was expressed and purified from an E. coli dnaK-minus strain (Figure 2(a)). The E. coli dnaK-minus strain was used to eliminate endogenous DnaK, the bacterial homologue of Hsp70. Soluble TbHsp70.c was successfully purified by nickel-affinity chromatography under non-denaturing conditions and anti-TbHsp70.c peptide antibodies recognized full-length TbHsp70.c at 73 kDa, confirmed by western analysis (Figure 2(a)). 600 mg of protein was purified from 1 L of E. coli cells and was of sufficient purity for subsequent in vitro assays. An alternative strategy was adopted for the purifications of recombinant TcHsp70B and Tbj2 to eliminate co-purifying DnaK due to a lack of an E. coli dnaK-minus strain compatible with the pET vectors. Modifications to the nickel-affinity chromatography protocol included the addition of 20% glycerol and 10 mM ATP to the wash steps. The non-denaturing purification resulted in the removal of co-purified DnaK, confirmed by western analysis, from both the TcHsp70B (Figure 2(b)) and Tbj2 (Figure 2(c)) purifications. For the TcHsp70B and Tbj2 purifications, 1176 mg and 900 mg of protein were purified from 1 L of E. coli cells, respectively, and the elimination of DnaK warranted the use of TcHsp70B and Tbj2 in subsequent in vitro assays.

TbHsp70.c was able to suppress the protein aggregation of chemically denatured rhodanese in a dose-dependent manner (Figure 3). TcHsp70B, an orthologue of Bos taurus HSPA8, was used as a positive control. In addition to demonstrating typical chaperone properties [32, 34], the previously characterized TcHsp70B, also homologous to TbHsp70, contains an intact C-terminal EEVD motif. The addition of TbHsp70.c and TcHsp70B resulted in a marked increase of aggregation suppression in a dose-dependent manner (Figure 3). Tbj2 (0.5 [micro]M, 0.7 [micro]M, 1 [micro]M) resulted in 4.1%, 8.3%, and 14.2% suppression of rhodanese aggregation, respectively. To investigate the ability of Tbj2 to enhance the holdase function of TbHsp70.c, a fixed concentration of TbHsp70.c was used and Tbj2 concentrations were varied. The addition of Tbj2 at a submolar concentration to TbHsp70.c resulted in 27.7% suppression of rhodanese aggregation (Figure 3). Equal concentrations of Tbj2 and TbHsp70.c resulted in 37.5% suppression of rhodanese aggregation, which was comparable to the 41.2% suppression produced by TcHsp70B at equimolar concentrations to Tbj2. Tbj2 in partnership with TbHsp70.c demonstrated increased aggregation suppression. At equimolar concentrations Tbj2 demonstrated a synergistic effect and thus the ability to function as a co-chaperone to both TcHsp70B and TbHsp70.c.

MDH was used as a second substrate to establish whether TbHsp70.c and Tbj2 could suppress aggregation of MDH. BSA was used as a negative control and had no effect on MDH aggregation (data not shown). TcHsp70B resulted in 53% suppression of MDH aggregation (Figure 4). A dose response was evident upon the addition of various concentrations of TbHsp70.c as turbidity levels decreased with an increase in chaperone concentration (Figure 4). A similar result was obtained for Tbj2 where increased chaperone concentrations caused decreased turbidity and a dose-dependent suppression of MDH aggregation (Figure 4). The ability of Tbj2 to enhance the holdase function of TbHsp70.c was assessed by maintaining constant TbHsp70.c concentrations and varying those of Tbj2 (Figure 4). TbHsp70.c (0.5 [micro]M) resulted in 61.8% suppression of MDH aggregation (Figure 4). The addition of Tbj2 at a submolar concentration (0.3 [micro]M) to TbHsp70.c resulted in 66.9% MDH aggregation suppression and Tbj2 at molar excess (0.7 [micro]M) resulted in 85% suppression of MDH aggregation (Figure 4). Tbj2 concentrations of 0.3 [micro]M and 0.7 [micro]M enhanced TbHsp70.c chaperone activity; however, the increase in turbidity was not enough to be an additive effect. Equal concentrations of Tbj2 and control protein TcHsp70B resulted in 93.9% suppression of MDH aggregation, which appeared to be an additive effect (Figure 4). Tbj2 did not demonstrate the ability to co-chaperone either TbHsp70.c or Tchsp70B using MDH as a substrate. Tbj2 may have been binding as substrate to TbHsp70.c, thus resulting in the decreased suppression of MDH aggregation that was observed.

The ability of Tbj2 to stimulate the basal ATPase activity of TbHsp70.c and TcHsp70B was investigated. TbHsp70.c was determined to have a basal ATPase activity of 7.6 nmol Pi/min/mg and TcHsp70B a basal ATPase activity of 18.3 nmol Pi/min/mg. The basal ATPase activity of TbHsp70.c and TcHsp70B was represented as 100% (Figure 5). Equal concentrations of Tbj2 and TbHsp70.c resulted in a significant 1.62-fold stimulation of the basal ATPase activity of TbHsp70.c (Figure 5). Equal concentrations of Tbj2 and TcHsp70B caused a slightly lower but still significant 1.39-fold stimulation of TcHsp70B basal ATPase activity (Figure 5). Tbj2 at 2-fold molar excess to TbHsp70.c and TcHsp70B resulted in a significant 2.88-fold enhancement of the basal ATPase activity of TbHsp70.c and a significant 2.62-fold stimulation of TcHsp70B ATPase activity (Figure 5). TbHsp70.c, TcHsp70B, and Tbj2 denatured by boiling displayed no ATPase activity (data not shown).

Under conditions of stress, a cell responds by increasing the synthesis of heat shock proteins to manage the elevated levels of denatured proteins. T. b. brucei 427 V221 cells were exposed to heat shock by incubating them at 42[degrees]C for one hour. Recombinant TbHsp70.c purified from E. coli BB1994 cells was used as a positive control. Even though there was no notable diference in the TbHsp70.c protein levels on the SDS-PAGE gel, TbHsp70.c protein expression proved to be inducible by heat stress, as shown by an increase in the top band in the western analysis (Figure 6). Two bands were detected by the anti-TbHsp70.c peptide antibody. The top band at 73 kDa increased in intensity from 37[degrees]C to 42[degrees]C indicating that at 37[degrees]C TbHsp70.c was expressed in bloodstream form cells and upon exposure to heat stress TbHsp70.c was upregulated. Interestingly, the expression level of the non-specific 68 kDa band, detected by anti-TbHsp70.c peptide antibodies, remained constant upon heat shock, suggesting it to be a separate protein and not a degradation product of TbHsp70.c (Figure 6).

4. Discussion

A study of the evolutionary relationships between kinetoplastid Hsp70 proteins and typical Hsp70 proteins has revealed a novel and divergent group of proteins, the orthologues TbHsp70.c, TcHsp70.c, and LmHsp70.c. This is the first report of the successful expression and purification of TbHsp70.c. Tbj2 was selected as a probable co-chaperone of TbHsp70.c due to the presence of its functional J-domain and because of its predicted cytosolic localization (data not shown). When studying molecular chaperones, the presence of DnaK is a major concern due to the possibility that basal expression of bacterial or co-purified DnaK could mask the chaperone activity of the T. brucei heat shock proteins under investigation. The co-purification of DnaK is likely as a result of denatured exposed surfaces of the target protein interacting with DnaK by acting as a substrate. Using an E. coli dnaK-minus strain and modifications to the purification protocol, DnaK was eliminated from the TbHsp70.c and the Tbj2 and TcHsp70B purifications, respectively.

Amongst the various roles of Hsp70 proteins is the ability to act as holdases, preventing aggregation of proteins [6]. Demonstration of the holdase-function, by suppressing protein aggregation, is used to display chaperone activity [48, 49]. MDH aggregation suppression assays are often performed in the absence of ATP [50, 51]. The addition of ATP decreases the affinity of an Hsp70 protein for MDH, resulting in its release and subsequent re-aggregation [52]. A loss of affinity for substrate in the presence of ATP has been demonstrated for P. falciparum Hsp70 [53], E. coli Hsc66, DnaK [54] and bovine Hsp90 [55]. The model thermolabile substrate MDH was used in this study to investigate the ability of TbHsp70.c and Tbj2, in isolation and in partnership, to suppress the heat-induced aggregation of MDH. A second substrate, rhodanese, was selected to investigate whether the substrate binding specificity of TbHsp70.c for rhodanese would differ considering the presence of fewer hydrophobic residues within rhodanese than in MDH. A recent in silico study using an E. coli DnaK L484W mutant predicted that an increase in hydrogen bonds and hydrophobic interactions allows an enhanced interaction between chaperone and substrate [56]. TbHsp70.c was shown to bind and suppress aggregation of both rhodanese and MDH, thereby displaying typical chaperone activity. However, TbHsp70.c suppressed aggregation of MDH to a greater degree than was observed for rhodanese.

Hsp70s generally function in cooperation with Hsp40s, where Hsp40 either mediates the interaction of Hsp70 with its substrate or "holds" the substrate and recruits Hsp70 to the unfolded polypeptide [57]. Hsp40 proteins are able to bind unfolded substrates independently of Hsp70 proteins and prevent their aggregation [18, 58]. Once bound, the substrate is transferred to Hsp70 by the J-protein; at the same time Hsp40 stabilizes the Hsp70-substrate association by stimulating the ATPase activity of Hsp70 [58]. Tbj2 successfully suppressed aggregation of MDH. A similar result was seen for the homologue of Tbj2, Tcj2, in its ability to independently suppress aggregation of MDH [37]. However, Tbj2 showed a considerably decreased ability to suppress rhodanese aggregation. The reduced chaperone activity observed in this study using rhodanese could furthermore be as a result of non-productive and aggregationprone intermediates formed whilst rhodanese refolds [59]. In the presence of TbHsp70.c, Tbj2 appeared to enhance the suppression of aggregation of rhodanese. The effect of Tbj2 on both TbHsp70.c and TcHsp70B was additive rather than synergistic when using MDH. A similar result was observed during the suppression of aggregation of MDH by Plasmodium falciparum Hsp40 and Hsp70 [51]. The ability of a Type III Hsp40 protein, Tbj1, to function as a co-chaperone was supported by the findings that Tbj1 assisted Trypanosoma cruzi Hsp70 and Medicago sativa Hsp70 in suppression of MDH aggregation [37]. Suppression of protein aggregation assays has also been used to successfully determine the effect of small molecule modulators on the abilities of PfHsp70 proteins to suppress the aggregation of alcohol dehydrogenase [60] and MDH [50]. The ability of TbHsp70.c to successfully suppress aggregation of two individual substrates was not surprising. Even though some conservation has been lost in the TbHsp70.c hydrophobic arch, some residues are replaced by acidic and aliphatic residues and the hydrophobic pocket, represented by the valine residue, is well conserved (data not shown).

Enhanced Hsp70 ATPase activity is specific and is modulated through the interaction of an Hsp40 partner. Tbj2 in excess stimulated the ATP hydrolysis activity of TbHsp70.c approximately 3-fold. This data would suggest that Tbj2 acts as a co-chaperone by means of its J-domain interacting with the ATPase domain of TbHsp70.c, either recruiting substrates to the Hsp70 or merely mediating the interaction of the Hsp70 with its substrate and stimulating the ATPase activity of the Hsp70. However, the level of ATPase activity stimulation by Tbj2 is low in comparison to what has previously been observed for Hsp70-Hsp40 partnerships. Yeast Hsp40, Ydj1p, was shown to stimulate the ATPase activity of yeast Hsp70, Ssa1p, by 6-8-fold [18, 61, 62]. Tbj2, homologue of Tcj2, demonstrated a greater stimulation of TbHsp70.c ATPase activity than was observed for Tcj2-stimulated ATPase activity of TcHsp70B [34]. The low stimulation of the ATPase activity of TcHsp70 by Tcj2 was suggested to be as a result of a masking effect of the already very high basal ATPase activity of TcHsp70B, reported to be 100 times greater than that observed for human Hsp70 [34]. Further characterization of the ATPase activity of TbHsp70.c would entail investigating the activation of the ATPase activity of TbHsp70.c by various substrates. Maximal stimulation of the ATPase activity of Hsp70 proteins has been demonstrated to take place in the presence of both co-chaperone and substrate [63].

To date, very little research has been performed on the heat shock response within T. brucei. The focus has been on investigating the effect of heat stress on T. cruzi and/or its vector, Panstrongylus megistus [64] as well as on molecular chaperones belonging to the T. cruzi parasite [65]. A study in which T. b. brucei bloodstream form cultures were exposed to heat shock resulted in the upregulation of the expression levels of TbHsp70.c. This finding would imply that TbHsp70.c is required for protein quality control not only under normal conditions but also when the cell is placed under thermal stress. This is the first report of data showing that the expression levels of TbHsp70.c are increased by heat stress. TcHsp70 mRNA levels showed a very significant four-fold upregulation upon heat stress at 37[degrees]C when compared to mRNA levels at 28[degrees]C [65].

5. Conclusions

The ability of Tbj2 to significantly enhance the basal ATPase activity of TbHsp70.c suggests that Tbj2 functions as a co-chaperone of TbHsp70.c. However, further experimental analyses including binding studies and co-localization will need to be performed to conclusively confirm Tbj2 as co-chaperone of TbHsp70.c. Furthermore, the possibility of other cytoplasmic Tbj proteins functioning as co-chaperones of TbHsp70.c will need to be investigated. Due to its atypical features, TbHsp70.c is likely to interact with a specific set of protein substrates in the cell. TbHsp70.c is the first T. brucei Hsp70 protein to be functionally characterized, along with its probable partnership with co-chaperone Tbj2. This research opens up prospects for further studies of the yet unexplored multiple Hsp70/Hsp40 partnerships in T. brucei. Future research would entail isolating and characterizing the remaining 11 Hsp70 proteins from T. brucei to enable differentiation between unique and canonical features and furthermore investigating which of them form partnerships with the 65 Hsp40 proteins. Characterization of these and other chaperone/co-chaperone interactions could further enhance understanding of the cell biology of T. brucei.

Conflict of Interests

The authors declare that they have no conflict of interests regarding the publication of this paper.


This research was funded by a National Research Foundation (NRF) Tuthuka Grant. The authors are grateful to Ms F. Mokoena for her expertise in phylogeny. Dr. M. H. Ludewig is the recipient of a Claude Leon Foundation Postdoctoral Fellowship.


[1] J. L. Brodsky and A. A. McCracken, "ER protein quality control and proteasome-mediated protein degradation," Seminars in Cell and Developmental Biology, vol. 10, no. 5, pp. 507-513, 1999.

[2] B. D. Hamman, L. M. Hendershot, and A. E. Johnson, "BiP maintains the permeability barrier of the ER membrane by sealing the lumenal end of the translocon pore before and early in translocation," Cell, vol. 92, no. 6, pp. 747-758, 1998.

[3] D. K. Eggers, W. J. Welch, and W. J. Hansen, "Complexes between nascent polypeptides and their molecular chaperones in the cytosol of mammalian cells," Molecular Biology of the Cell, vol. 8, no. 8, pp. 1559-1573, 1997.

[4] M. Zylicz, D. Ang, K. Liberek, and C. Georgopoulos, "Initiation of [lambda] DNA replication with purified host- and bacteriophage-encoded proteins: the role of the dnaK, dnaJ and grpE heat shock proteins," EMBO Journal, vol. 8, no. 5, pp. 1601-1608, 1989.

[5] M. Daugaard, M. Rohde, and M. Jaattela, "The heat shock protein 70 family: highly homologous proteins with overlapping and distinct functions," FEBS Letters, vol. 581, no. 19, pp. 3702-3710, 2007.

[6] S. V. Slepenkov and S. N. Witt, "The unfolding story of the Escherichia coli Hsp70 DnaK: is DnaK a holdase or an unfoldase?" Molecular Microbiology, vol. 45, no. 5, pp. 1197-1206, 2002.

[7] K. M. Flaherty, C. DeLuca-Flaherty, and D. B. McKay, "Three-dimensional structure of the ATPase fragment of a 70K heat-shock cognate protein," Nature, vol. 346, no. 6285, pp. 623-628, 1990.

[8] T.-F. Wang, J.-H. Chang, and C. Wang, "Identification of the peptide binding domain of hsc70. 18-kilodalton fragment located immediately after ATPase domain is sufficient for high affinity binding," Journal of Biological Chemistry, vol. 268, no. 35, pp. 26049-26051, 1993.

[9] J. S. McCarty, A. Buchberger, J. Reinstein, and B. Bukau, "The role of ATP in the functional cycle of the DnaK chaperone system," Journal of Molecular Biology, vol. 249, no. 1, pp. 126-137, 1995.

[10] J. L. Brodsky and A. Bracher, "Nucleotide exchange factors for Hsp70 molecular chaperones," in Networking of Chaperones By Co-Chaperones, G. L. Blatch, Ed., pp. 26-37, Landes Bioscience, Austin, Tex, USA; Springer Science Business Media, New York, NY, USA, 2007.

[11] C. Scheufler, A. Brinker, G. Bourenkov et al., "Structure of TPR domain-peptide complexes: critical elements in the assembly of the Hsp70-Hsp90 multichaperone machine," Cell, vol. 101, no. 2, pp. 199-210, 2000.

[12] J. Li, Y. Wu, X. Qian, and B. Sha, "Crystal structure of yeast Sis1 peptide-binding fragment and Hsp70 Ssa1 C-terminal complex," Biochemical Journal, vol. 398, no. 3, pp. 353-360, 2006.

[13] J. Demand, J. Luders, and J. Hohfeld, "The carboxy-terminal domain of Hsc70 provides binding sites for a distinct set of chaperone cofactors," Molecular and Cellular Biology, vol. 18, no. 4, pp. 2023-2028, 1998.

[14] P. Genevaux, A. Wawrzynow, M. Zylicz, C. Georgopoulos, and W. L. Kelley, "DjlA is a third DnaK co-chaperone of Escherichia coli, and DjlA- mediated induction of colanic acid capsule requires DjlA-DnaK interaction," Journal of Biological Chemistry, vol. 276, no. 11, pp. 7906-7912, 2001.

[15] P. Wittung-Stafshede, J. Guidry, B. E. Horne, and S. J. Landry, "The J-domain of Hsp40 couples ATP hydrolysis to substrate capture in Hsp70," Biochemistry, vol. 42, no. 17, pp. 4937-4944, 2003.

[16] J. Li, X. Qian, and B. Sha, "The crystal structure of the yeast Hsp40 Ydj1 complexed with its peptide substrate," Structure, vol. 11, no. 12, pp. 1475-1483, 2003.

[17] J. Hu, Y. Wu, J. Li, X. Qian, Z. Fu, and B. Sha, "The crystal structure of the putative peptide-binding fragment from the human Hsp40 protein Hdj1," BMC Structural Biology, vol. 8, article 3, 2008.

[18] D. M. Cyr, T. Langer, and M. G. Douglas, "DnaJ-like proteins: molecular chaperones and specific regulators of Hsp70," Trends in Biochemical Sciences, vol. 19, no. 4, pp. 176-181, 1994.

[19] J. L. Johnson and E. A. Craig, "An essential role for the substrate-binding region of Hsp40s in Saccharomyces cerevisiae," Journal of Cell Biology, vol. 152, no. 4, pp. 851-856, 2001.

[20] B. Sha, S. Lee, and D. M. Cyr, "The crystal structure of the peptide-binding fragment from the yeast Hsp40 protein Sis1," Structure, vol. 8, no. 8, pp. 799-807, 2000.

[21] Y. Wu, J. Li, Z. Jin, Z. Fu, and B. Sha, "The crystal structure of the C-terminal fragment of yeast Hsp40 Ydj1 reveals novel dimerization motif for Hsp40," Journal of Molecular Biology, vol. 346, no. 4, pp. 1005-1011, 2005.

[22] F. Hennessy, W. S. Nicoll, R. Zimmermann, M. E. Cheetham, and G. L. Blatch, "Not all J domains are created equal: implications for the specificity of Hsp40-Hsp70 interactions," Protein Science, vol. 14, no. 7, pp. 1697-1709, 2005.

[23] T. Manful, J. Mulindwa, F. M. Frank, C. E. Clayton, and E. Matovu, "A search for Trypanosoma brucei rhodesiense diagnostic antigens by proteomic screening and targeted cloning," PLoS ONE, vol. 5, no. 3, Article ID e9630, 2010.

[24] K. Vickerman, "Developmental cycles and biology of pathogenic trypanosomes," British Medical Bulletin, vol. 41, no. 2, pp. 105-114, 1985.

[25] V. Delespaux and H. P. de Koning, "Drugs and drug resistance in African trypanosomiasis," Drug Resistance Updates, vol. 10, no. 1-2, pp. 30-50, 2007.

[26] C. G. Evans, L. Chang, and J. E. Gestwicki, "Heat shock protein 70 (Hsp70) as an emerging drug target," Journal of Medicinal Chemistry, vol. 53, no. 12, pp. 4585-4602, 2010.

[27] L. Bhagat, V. P. Singh, R. K. Dawra, and A. K. Saluja, "Sodium arsenite induces heat shock protein 70 expression and protects against secretagogue-induced trypsinogen and NF-[kappa]B activation," Journal of Cellular Physiology, vol. 215, no. 1, pp. 37-46, 2008.

[28] X.-Q. Bao and G.-T. Liu, "Induction of overexpression of the 27- and 70-kDa heat shock proteins by bicyclol attenuates concanavalin A-induced liver injury through suppression of nuclear factor-[kappa]B in mice," Molecular Pharmacology, vol. 75, no. 5, pp. 1180-1188, 2009.

[29] G. Banumathy, V. Singh, S. R. Pavithra, and U. Tatu, "Heat shock protein 90 function is essential for Plasmodium falciparum growth in human erythrocytes," Journal of Biological Chemistry, vol. 278, no. 20, pp. 18336-18345, 2003.

[30] R. Pallavi, P. Acharya, S. Chandran, J. P. Daily, and U. Tatu, "Chaperone expression profiles correlate with distinct physiological states of Plasmodium falciparum in malaria patients," Malaria Journal, vol. 9, no. 1, article 236, 2010.

[31] G. M. Krautz, J. D. Peterson, L. M. Godsel, A. U. Krettli, and D. M. Engman, "Human antibody responses to Trypanosoma cruzi 70-kD heat-shock proteins," American Journal of Tropical Medicine and Hygiene, vol. 58, no. 2, pp. 137-143, 1998.

[32] L. Planelles, M. C. Tomas, C. Alonso, and M. C. Lopez, "DNA immunization with Trypanosoma cruzi HSP70 fused to the KMP11 protein elicits a cytotoxic and humoral immune response against the antigen and leads to protection," Infection and Immunity, vol. 69, no. 10, pp. 6558-6563, 2001.

[33] A. A. Arif, L. Gao, C. D. Davis, and D. S. Helm, "Antibody response to heat shock proteins and histopathology in mice infected with Trypanosomacruzi and maintained at elevated temperature," Journal of Parasitology, vol. 85, no. 6, pp. 1089-1099, 1999.

[34] A. L. Edkins, M. H. Ludewig, and G. L. Blatch, "A Trypanosoma cruzi heat shock protein 40 is able to stimulate the adenosine triphosphate hydrolysis activity of heat shock protein 70 and can substitute for a yeast heat shock protein 40," International Journal of Biochemistry and Cell Biology, vol. 36, no. 8, pp. 1585-1598, 2004.

[35] C. Folgueira and J. M. Requena, "A postgenomic view of the heat shock proteins in kinetoplastids," FEMS Microbiology Reviews, vol. 31, no. 4, pp. 359-377, 2007.

[36] C. A. Louw, M. H. Ludewig, J. Mayer, and G. L. Blatch, "The Hsp70 chaperones of the Tritryps are characterized by unusual features and novel members," Parasitology International, vol. 59, no. 4, pp. 497-505, 2010.

[37] C. A. Louw, M. H. Ludewig, and G. L. Blatch, "Overproduction, purification and characterisation of Tbj1, a novel Type III Hsp40 from Trypanosoma brucei, the African sleeping sickness parasite," Protein Expression and Purification, vol. 69, no. 2, pp. 168-177, 2010.

[38] S. Alsford, D. J. Turner, S. O. Obado et al., "High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome," Genome Research, vol. 21, no. 6, pp. 915-924, 2011.

[39] M. H. Ludewig, A. Burger, A. Boshoff, D. Horn, and G. L. Blatch, "Trypanosoma brucei J protein 2 is a stress inducible and essential Hsp40," International Journal for Parasitology. In press.

[40] M. Aslett, C. Aurrecoechea, M. Berriman et al., "TriTrypDB: a functional genomic resource for the Trypanosomatidae," Nucleic Acids Research, vol. 38, no. 1, pp. D457-D462, 2009.

[41] C. Hertz-Fowler, C. S. Peacock, V. Wood et al., "GeneDB: a resource for prokaryotic and eukaryotic organisms," Nucleic Acids Research, vol. 32, pp. D339-D343, 2004.

[42] E. W. Sayers, T. Barrett, D. A. Benson et al., "Database resources of the national center for biotechnology information," Nucleic Acids Research, vol. 37, no. 9, pp. 3124-3139, 2011.

[43] K. Tamura, D. Peterson, N. Peterson, G. Stecher, M. Nei, and S. Kumar, "MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods," Molecular Biology and Evolution, vol. 28, no. 10, pp. 2731-2739, 2011.

[44] R. C. Edgar, "MUSCLE: multiple sequence alignment with high accuracy and high throughput," Nucleic Acids Research, vol. 32, no. 5, pp. 1792-1797, 2004.

[45] R. K. Allan, D. Mok, B. K. Ward, and T. Ratajczak, "Modulation of chaperone function and cochaperone interaction by novobiocin in the C-terminal domain of Hsp90: evidence that coumarin antibiotics disrupt Hsp90 dimerization," Journal of Biological Chemistry, vol. 281, no. 11, pp. 7161-7171, 2006.

[46] M. Botha, E.-R. Pesce, and G. L. Blatch, "The Hsp40 proteins of Plasmodium falciparum and other apicomplexa: regulating chaperone power in the parasite and the host," International Journal of Biochemistry and Cell Biology, vol. 39, no. 10, pp. 1781-1803, 2007.

[47] S. Chifflet, A. Torriglia, R. Chiesa, and S. Tolosa, "A method for the determination of inorganic phosphate in the presence of labile organic phosphate and high concentrations of protein: application to lens ATPase," Analytical Biochemistry, vol. 168, no. 1, pp. 1-4, 1988.

[48] P. Goloubinoff, A. Mogk, A. P. Ben Zvi, T. Tomoyasu, and B. Bukau, "Sequential mechanism of solubilization and refolding of stable protein aggregates by a bichaperone network," Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 24, pp. 13732-13737, 1999.

[49] E. Basha, G. J. Lee, B. Demeler, and E. Vierling, "Chaperone activity of cytosolic small heat shock proteins from wheat," European Journal of Biochemistry, vol. 271, no. 8, pp. 1426-1436, 2004.

[50] I. L. Cockburn, E.-R. Pesce, J. M. Pryzborski et al., "Screening for small molecule modulators of Hsp70 chaperone activity using protein aggregation suppression assays: inhibition of the plasmodial chaperone PfHsp70-1," Biological Chemistry, vol. 392, no. 5, pp. 431-438, 2011.

[51] M. Botha, A. N. Chiang, P. B. Needham et al., "Plasmodium falciparum encodes a single cytosolic type i Hsp40 that functionally interacts with Hsp70 and is upregulated by heat shock," Cell Stress and Chaperones, vol. 16, no. 4, pp. 389-401, 2011.

[52] A. Shonhai, M. Botha, T. A. P. De Beer, A. Boshoff, and G. L. Blatch, "Structure-function study of a Plasmodium falciparum Hsp70 using three dimensional modelling and in vitro analyses," Protein and Peptide Letters, vol. 15, no. 10, pp. 1117-1125, 2008.

[53] A. Shonhai, A. Boshoff, and G. L. Blatch, "The structural and functional diversity of Hsp70 proteins from Plasmodium falciparum," Protein Science, vol. 16, no. 9, pp. 1803-1818, 2007.

[54] J. J. Silberg, K. G. Hoff, and L. E. Vickery, "The Hsc66-Hsc20 chaperone system in Escherichia coli: chaperone activity and interactions with the DnaK-DnaJ-GrpE system," Journal of Bacteriology, vol. 180, no. 24, pp. 6617-6624, 1998.

[55] J. C. Young, C. Schneider, and F. U. Hartl, "In vitro evidence that hsp90 contains two independent chaperone sites," FEBS Letters, vol. 418, no. 1-2, pp. 139-143, 1997.

[56] L. Xu, N. Hasin, M. Shen et al., "Using steered molecular dynamics to predict and assess Hsp70 substrate-binding domain mutants that alter prion propogation," PLOS Computational Biology, vol. 9, Article ID e1002896, 2013.

[57] J. C. Young, N. J. Hoogenraad, and F. U. Hartl, "Molecular chaperones Hsp90 and Hsp70 deliver preproteins to the mitochondrial import receptor Tom70," Cell, vol. 112, no. 1, pp. 41-50, 2003.

[58] J. C. Young, V. R. Agashe, K. Siegers, and F. U. Hartl, "Pathways of chaperone-mediated protein folding in the cytosol," Nature Reviews Molecular Cell Biology, vol. 5, no. 10, pp. 781-791, 2004.

[59] M. Panda, B. M. Gorovits, and P. M. Horowitz, "Productive and nonproductive intermediates in the folding of denatured rhodanese," Journal of Biological Chemistry, vol. 275, no. 1, pp. 63-70, 2000.

[60] T. N. C. Ramya, N. Surolia, and A. Surolia, "15-Deoxyspergualin modulates Plasmodium falciparum heat shock protein function," Biochemical and Biophysical Research Communications, vol. 348, no. 2, pp. 585-592, 2006.

[61] A. J. Caplan, J. Tsai, P. J. Casey, and M. G. Douglas, "Farnesylation of YDJ1p is required for function at elevated growth temperatures in Saccharomyces cerevisiae," Journal of Biological Chemistry, vol. 267, no. 26, pp. 18890-18895, 1992.

[62] S. W. Fewell, C. M. Smith, M. A. Lyon et al., "Small molecule modulators of endogenous and co-chaperone-stimulated Hsp70 ATPase activity," Journal of Biological Chemistry, vol. 279, no. 49, pp. 51131-51140, 2004.

[63] T. Laufen, M. P. Mayer, C. Beisel et al., "Mechanism of regulation of Hsp70 chaperones by DnaJ cochaperones," Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 10, pp. 5452-5457, 1999.

[64] D. Perez-Morales, H. Lanz-Mendoza, G. Hurtado, R. Martinez-Espinosa, and B. Espinoza, "Proteomic analysis of Trypanosoma cruzi epimastigotes subjected to heat shock," Journal of Biomedicine and Biotechnology, vol. 2012, Article ID 902803, 9 pages, 2012.

[65] J. M. Requena, A. Jimenez-Ruiz, M. Soto et al., "Regulation of hsp70 expression in Trypanosoma cruzi by temperature and growth phase," Molecular and Biochemical Parasitology, vol. 53, no. 1-2, pp. 201-212, 1992.

Biomedical and Biotechnology Research Unit (BioBRU), Department of Biochemistry, Microbiology and Biotechnology, Rhodes University, P.O. Box 94, Grahamstown 6140, South Africa

Correspondence should be addressed to Aileen Boshoff;

Received 31 October 2013; Revised 23 December 2013; Accepted 9 January 2014; Published 24 February 2014

Academic Editor: Takeshi Agatsuma

Copyright [c] 2014 Adelle Burger et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
COPYRIGHT 2014 Hindawi Limited
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2014 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Research Article
Author:Burger, Adelle; Ludewig, Michael H.; Boshoff, Aileen
Publication:Journal of Parasitology Research
Article Type:Report
Date:Jan 1, 2014
Previous Article:Echinococcus granulosus prevalence in dogs in Southwest Nigeria.
Next Article:Isolation of intestinal parasites of public health importance from cockroaches (Blattella germanica) in Jimma Town, Southwestern Ethiopia.

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters |